Stem Cell Implantation in Patients Undergoing CABG

NCT01721902 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

23

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminiated due the lack of recruitment.

Conditions

Ischemic Cardiomyopathy
Coronary Artery Disease

Interventions

DEVICE: Autologous CD133+ Bone Marrow Stem Cells
OTHER: Carrier Solution

Sponsor

Miltenyi Biotec, Inc.